These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 19090931)
21. Ticagrelor, a platelet aggregation inhibitor for the potential prevention and treatment of arterial thrombosis and acute coronary syndromes. Doggrell SA IDrugs; 2009 May; 12(5):309-17. PubMed ID: 19431096 [TBL] [Abstract][Full Text] [Related]
23. Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome. Dupont AG; Gabriel DA; Cohen MG Thromb Res; 2009 May; 124(1):6-13. PubMed ID: 19324398 [TBL] [Abstract][Full Text] [Related]
24. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009 [TBL] [Abstract][Full Text] [Related]
25. Monitoring platelet function to reduce the risk of ischemic and bleeding complications. Price MJ Am J Cardiol; 2009 Feb; 103(3 Suppl):35A-39A. PubMed ID: 19166711 [TBL] [Abstract][Full Text] [Related]
26. Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes. Baker WL; White CM Am J Cardiovasc Drugs; 2009; 9(4):213-29. PubMed ID: 19655817 [TBL] [Abstract][Full Text] [Related]
27. Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention. Rajan L; Moliterno DJ Eur Heart J; 2009 Jul; 30(14):1687-9. PubMed ID: 19429914 [No Abstract] [Full Text] [Related]
28. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Rao RV; Goodman SG; Yan RT; Spencer FA; Fox KA; DeYoung JP; Rose B; Grondin FR; Gallo R; Gore JM; Yan AT; Am Heart J; 2009 Apr; 157(4):642-50.e1. PubMed ID: 19332190 [TBL] [Abstract][Full Text] [Related]
29. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. Depta JP; Cannon CP; Fonarow GC; Zhao X; Peacock WF; Bhatt DL; Am J Cardiol; 2009 Nov; 104(9):1171-8. PubMed ID: 19840557 [TBL] [Abstract][Full Text] [Related]
30. Acute coronary syndromes: a Canadian perspective. Fitchett DH Can J Cardiol; 2011; 27 Suppl A():S385-6. PubMed ID: 22118041 [No Abstract] [Full Text] [Related]
31. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation. Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391 [TBL] [Abstract][Full Text] [Related]
32. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Manoukian SV Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355 [TBL] [Abstract][Full Text] [Related]
33. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies. Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970 [TBL] [Abstract][Full Text] [Related]
37. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. Jolly SS; Faxon DP; Fox KA; Afzal R; Boden WE; Widimsky P; Steg PG; Valentin V; Budaj A; Granger CB; Joyner CD; Chrolavicius S; Yusuf S; Mehta SR J Am Coll Cardiol; 2009 Jul; 54(5):468-76. PubMed ID: 19628124 [TBL] [Abstract][Full Text] [Related]
39. Acute coronary syndrome: new and evolving therapies. St Laurent P Crit Care Nurs Clin North Am; 2011 Dec; 23(4):559-71. PubMed ID: 22118114 [TBL] [Abstract][Full Text] [Related]
40. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel. Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]